Cypralis

Cypralis Focuses on the Discovery and Development of Innovative Therapies for Modulating Peptidyl-Prolyl Isomerases, Known as PPIases, a Large Family of Druggable Protein Targets Involved in Many Acute and Chronic Diseases.